BioCorRx Inc. (BICX)
USD 0.43
(-14.0%)
USD 0.43
(-14.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 89.16 Thousand USD | -58.31% |
| 2022 | 213.84 Thousand USD | 342.99% |
| 2021 | 48.27 Thousand USD | -60.63% |
| 2020 | 122.62 Thousand USD | -48.96% |
| 2019 | 240.25 Thousand USD | -36.21% |
| 2018 | 376.65 Thousand USD | -42.69% |
| 2017 | 657.27 Thousand USD | -6.34% |
| 2016 | 701.77 Thousand USD | -24.11% |
| 2015 | 924.73 Thousand USD | -21.03% |
| 2014 | 1.17 Million USD | 63.77% |
| 2013 | 714.96 Thousand USD | -17.65% |
| 2012 | 868.16 Thousand USD | 12.49% |
| 2011 | 771.76 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4045.00 USD | 11.74% |
| 2024 Q1 | 3620.00 USD | -80.88% |
| 2023 FY | 89.16 Thousand USD | -58.31% |
| 2023 Q4 | 18.93 Thousand USD | 86.67% |
| 2023 Q3 | 10.14 Thousand USD | -48.33% |
| 2023 Q2 | 19.63 Thousand USD | -51.45% |
| 2023 Q1 | 40.44 Thousand USD | -51.2% |
| 2022 Q1 | 20.51 Thousand USD | 50.72% |
| 2022 FY | 213.84 Thousand USD | 342.99% |
| 2022 Q4 | 82.88 Thousand USD | -12.24% |
| 2022 Q3 | 94.44 Thousand USD | 490.18% |
| 2022 Q2 | 16 Thousand USD | -22.01% |
| 2021 Q2 | 15.71 Thousand USD | 55.25% |
| 2021 FY | 48.27 Thousand USD | -60.63% |
| 2021 Q3 | 8817.00 USD | -43.91% |
| 2021 Q4 | 13.61 Thousand USD | 54.39% |
| 2021 Q1 | 10.12 Thousand USD | -54.44% |
| 2020 Q4 | 22.22 Thousand USD | -25.45% |
| 2020 Q3 | 29.8 Thousand USD | -11.53% |
| 2020 Q2 | 33.69 Thousand USD | -8.67% |
| 2020 Q1 | 36.89 Thousand USD | -40.92% |
| 2020 FY | 122.62 Thousand USD | -48.96% |
| 2019 Q4 | 62.44 Thousand USD | 34.12% |
| 2019 Q2 | 65.97 Thousand USD | 1.08% |
| 2019 Q1 | 65.27 Thousand USD | 26.32% |
| 2019 Q3 | 46.56 Thousand USD | -29.43% |
| 2019 FY | 240.25 Thousand USD | -36.21% |
| 2018 Q4 | 51.67 Thousand USD | -34.24% |
| 2018 FY | 376.65 Thousand USD | -42.69% |
| 2018 Q3 | 78.58 Thousand USD | -20.36% |
| 2018 Q2 | 98.67 Thousand USD | -33.2% |
| 2018 Q1 | 147.72 Thousand USD | -10.42% |
| 2017 Q2 | 210.54 Thousand USD | 56.86% |
| 2017 Q1 | 134.22 Thousand USD | 15.86% |
| 2017 Q4 | 164.9 Thousand USD | 11.73% |
| 2017 FY | 657.27 Thousand USD | -6.34% |
| 2017 Q3 | 147.59 Thousand USD | -29.9% |
| 2016 Q4 | 115.84 Thousand USD | -30.88% |
| 2016 Q2 | 187.91 Thousand USD | -18.45% |
| 2016 FY | 701.77 Thousand USD | -24.11% |
| 2016 Q1 | 230.41 Thousand USD | 214.36% |
| 2016 Q3 | 167.59 Thousand USD | -10.81% |
| 2015 Q1 | 275.46 Thousand USD | -25.15% |
| 2015 Q3 | 118.19 Thousand USD | -74.18% |
| 2015 Q2 | 457.78 Thousand USD | 66.18% |
| 2015 FY | 924.73 Thousand USD | -21.03% |
| 2015 Q4 | 73.29 Thousand USD | -37.99% |
| 2014 Q3 | 434.04 Thousand USD | 82.36% |
| 2014 FY | 1.17 Million USD | 63.77% |
| 2014 Q1 | 130.82 Thousand USD | -99.98% |
| 2014 Q2 | 238 Thousand USD | 81.92% |
| 2014 Q4 | 368.04 Thousand USD | -15.21% |
| 2013 Q3 | 277.41 Thousand USD | -44.51% |
| 2013 Q2 | 499.95 Thousand USD | 29.12% |
| 2013 Q1 | 387.2 Thousand USD | 6.35% |
| 2013 FY | 714.96 Thousand USD | -17.65% |
| 2013 Q4 | 713.79 Million USD | 257207.75% |
| 2012 Q3 | 63.97 Thousand USD | -64.3% |
| 2012 Q2 | 179.2 Thousand USD | -31.31% |
| 2012 FY | 868.16 Thousand USD | 12.49% |
| 2012 Q1 | 260.88 Thousand USD | -66.2% |
| 2012 Q4 | 364.09 Thousand USD | 469.14% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | 771.76 Thousand USD | 0.0% |
| 2011 Q4 | 771.76 Thousand USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| The Amacore Group, Inc. | 28.82 Million USD | 99.691% |
| Arem Pacific Corporation | 343.47 Thousand USD | 74.042% |
| Assisted 4 Living, Inc. | 880.78 Thousand USD | 89.877% |
| Bionik Laboratories Corp. | 1.8 Million USD | 95.061% |
| Banyan Corp. | 5 Million USD | 98.218% |
| Clearday, Inc. | 12.48 Million USD | 99.286% |
| Dental Patient Care America, Inc. | 3.24 Million USD | 97.253% |
| Quantum Medical Transport, Inc. | 1310.14 USD | -6705.38% |
| Empower Clinics Inc. | 4.66 Million USD | 98.087% |
| First Choice Healthcare Solutions, Inc. | 29.98 Thousand USD | -197.349% |
| Selectis Health, Inc. | 36.78 Million USD | 99.758% |
| Ethema Health Corporation | 5.34 Million USD | 98.332% |
| HealthLynked Corp. | 5.72 Million USD | 98.442% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.24 Million USD | 99.036% |
| JRSIS Health Care Corporation | 3.46 Million USD | 97.425% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 453.75 Million USD | 99.98% |
| MedSmart Group Inc. | - USD | -Infinity% |
| North America Frac Sand, Inc. | 137.3 Thousand USD | 35.064% |
| Nova Leap Health Corp. | 26.17 Million USD | 99.659% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | 74.646% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | 99.151% |
| Raffles Medical Group Ltd | 536.52 Million USD | 99.983% |
| Ryman Healthcare Limited | 650.53 Million USD | 99.986% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 4.61 Million USD | 98.067% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | - USD | -Infinity% |
| Veltex Corporation | 838.65 Thousand USD | 89.369% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 1.12 Million USD | 92.054% |